Radiofrequency catheter ablation of supraventricular tachycardia in pregnancy: Ablation without fluoroscopic exposure
AuthorOmaygenç, Mehmet Onur
Karaca, İbrahim Oğuz
Güneş, Hacı Murat
MetadataShow full item record
CitationOmaygenç, M. O., Karaca, İ. O., Güler, E., Kızılırmak, F., Çakal, B., Güneş, H. M. ve Kılıçaslan, F. (2015). Radiofrequency catheter ablation of supraventricular tachycardia in pregnancy: Ablation without fluoroscopic exposure. Heart Rhythm, 12(5), 1057-1061. https://dx.doi.org/10.1016/j.hrthm.2015.01.037
Treatment of supraventricular tachycardia (SVT) during pregnancy can be troublesome. Antiarrhythmic drugs (especially beta-blockers and calcium channel blockers) are frequently used for treatment of symptomatic patients. However, routine and long-term use of these drugs is not recommended because most of them are classified as categories C and D by the US Food and Drug Administration.